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Abstract
Objective To systematically review the literature on the
Bosniak classification system in CT to determine its diagnos-
tic performance to diagnose malignant cystic lesions and the
prevalence of malignancy in Bosniak categories.
Methods A predefined database search was performed from 1
January 1986 to 18 January 2016. Two independent reviewers
extracted data on malignancy rates in Bosniak categories and
several covariates using predefined criteria. Study quality was
assessed using QUADAS-2. Meta-analysis included data
pooling, subgroup analyses, meta-regression and investigation
of publication bias.
Results A total of 35 studies, which included 2,578 lesions,
were investigated. Data on observer experience, inter-
observer variation and technical CT standards were insuffi-
ciently reported. The pooled rate of malignancy increased from
Bosniak I (3.2 %, 95 % CI 0–6.8, I2 = 5 %) to Bosniak II (6 %,
95 % CI 2.7–9.3, I2 = 32 %), IIF (6.7 %, 95 % CI 5–8.4, I2 =
0%), III (55.1 %, 95%CI 45.7–64.5, I2 = 89%) and IV (91%,
95 % CI 87.7–94.2, I2 = 36). Several study design-related in-
fluences onmalignancy rates and subsequent diagnostic perfor-
mance indices were identified.
Conclusion The Bosniak classification is an accurate tool with
which to stratify the risk of malignancy in renal cystic lesions.
Key points
• The Bosniak classification can accurately rule out
malignancy.
• Specificity remains moderate at 74% (95% CI 64–82).
• Follow-up examinations should be considered in Bosniak
IIF and Bosniak II cysts.
• Data on the influence of reader experience and inter-reader
variability are insufficient.
• Technical CT standards and publication year did not influ-
ence diagnostic performance.
Keywords Bosniak classification . Renal cysts . Kidney
cancer . Meta-analysis . Systematic review
Introduction
Contrast-enhanced computed tomography (CT) is considered
the imaging standard for the evaluation of renal cysts. Since its
introduction, the Bosniak classification for cystic renal masses
has foundwidespread acceptance. This is due to its simple struc-
ture, with a low number of diagnostic categories, each of them
associated with a suggestion for clinical management [1, 2]
(Table 1). Bosniak category I and category II lesions are simple
and minimally complex cysts and require no further work-up. A
Bosniak category III lesion is an indeterminate complex cyst
with an increased probability of malignancy ranging from
31 % to 100 %. For these cysts, the usual workup is surgery
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or, in selected cases, radiological follow-up [2]. Bosniak IV
cysts have clearly malignant features and surgical therapy is
recommended. In order to decrease unnecessary surgical inter-
ventions, a fifth category, Bosniak IIF has been introduced. This
category is a modification of the initial Bosniak classification
and describes a group of minimally complex cystic lesions, sep-
arate fromBosniak II and III, for which short-term (3–6months)
imaging surveillance is recommended [3] (Table 1).
While in cancer diagnosis a maximum sensitivity is always
desirable, false-positive findings may cause serious problems
and side effects, especially in vulnerable organs like the kid-
neys. Evidence-based clinical decision-making requires an as-
sessment of the accumulated empirical evidence. We noted a
discrepancy between the broad application of the Bosniak clas-
sification in clinical practice and the lack of a systematic review
and quantitative data synthesis demonstrating strengths and
weaknesses of this clinical decision rule. While the Bosniak
classification is clinically established, how accurate a positive
or negative result is and whether it may be reproduced using
different equipment or readers remains unknown. Through a
systematic review and meta-analysis, we aimed to address the
rate of malignancy in different Bosniak categories, the Bosniak
classification’s diagnostic accuracy and factors that influence
malignancy rates and diagnostic performance.
Materials and methods
Search strategy
Two readers independently performed a systematic search of
the Pubmed and Scopus databases including articles listed
from 1 January 1986 to 18 January 2016. The predefined
search term ‘Bosniak’ was used. The title and abstracts from
search results were screened and the full text of eligible studies
was retrieved. Only original, peer-reviewed research articles
that investigated the rate of renal cyst malignancy in adult
human subjects imaged by CT and classified according to
the Bosniak classification were eligible for this study.
Additional backward snowballing was performed scanning
the references of retrieved articles for additional studies [4].
Study selection
Both reviewers independently screened all identified records
for eligibility. A third arbitrator resolved any disagreement. If
the title and abstract did not provide sufficient information, the
full text was retrieved. Included were articles fulfilling the
following conditions: (1) a reference standard had to be
established either by histopathology workup or imaging
follow-up; (2) eligible studies had to be published in English
and (3) eligible studies had to include at least 15 patients.
Study quality was assessed using the QUADAS 2 tool. The
selection process by which the included studies were derived
for data extraction is shown in Fig. 1.
Data extraction
Two readers (one board-certified radiologist and one
board-certified urologist with >5 years experience in renal
imaging) performed raw data extraction. Afterwards, data
were checked for discrepancies which were solved in con-
sensus. A third reader controlled all data extracted by the
initial readers and corrected any discrepancies in
Table 1 The Bosniak





I Simple benign cyst: hairline-thin wall without septa,
calcifications, or solid components. Density similar
to water (≤15 HU), no enhancement after IV contrast
medium administration.
Benign, no further work-up necessary
II Benign cyst with minimal complicated features: may
present with a few hairline-thin septa, fine
calcifications in wall or septa. Further homogeneous
high-attenuation (>15 HU) lesions <3 cm in size,
sharp margins without enhancement
Benign, no further work-up necessary
IIF Similar to II but more complicated features: more
hairline-thin septa, minimal enhancement of septum
or wall. Further minimal thickening of septa/wall.
Calcifications may be nodular/thick. No enhancing
renal mass. Also, non-enhancing, high attenuation
(>15 HU) lesions >3 cm. Circumscribed margins
Probably benign, Follow-up
recommended
III Complicated cystic masses with thickened/irregular
walls or enhancing septa
Probably malignant, surgery or active
surveillance recommended




consensus with them. The following parameters were col-
lected and entered into a spreadsheet: author name; pub-
lication year; study design (retrospective vs. prospective);
number of patients and lesions; reference standard (histo-
pathology obtained by surgery or image-guided biopsy or
follow-up, duration of follow-up); reader number; experi-
ence and inter-reader agreement; and the technical param-
eters of CT. Numbers and final diagnosis (benign or ma-
lignant) were extracted for all Bosniak categories (I, II,
IIF, III and IV). Studies were further classified as either
reporting the prevalence of malignancy in certain Bosniak
subgroups only or diagnostic (including both lesions of
any Bosniak I, II or IIF, and Bosniak III or IV). Both
readers applied QUADAS 2 items to assess study quality
and likelihood of bias [5]. Again, if present, disagreement
was solved in consensus. In case of disagreement, a third
reader acted as an arbitrator.
Data synthesis and analysis
Analyses were performed using the software programs Open
Meta-Analyst for Mac OS Yosemite 10.10 (http://www.cebm.
brown.edu/open_meta) and StataSE 12 (StataCorp, College
Station, TX, USA). Raw extracted data from eligible articles
were used to construct forest plots of the rate of malignancy in
Bosniak categories I–IV; in addition, meta-regression was
performed in order to identify a possible influence on the
prevalence of malignancy by the factors listed above. In case
of positive findings, the forest plot was grouped according to
the respective variable identified by meta-regression. For the
assessment of heterogeneity, I2-statistics were calculated and
interpreted in accordance with the proposal of Higgins and
Thompson as showing low (I2 around 25 %), medium (I2
around 50 %) or high (I2 around 75 %) heterogeneity [6].
The diagnostic accuracy of the Bosniak classification for
the differentiation between benign and malignant renal cysts
was calculated by tabulating results into positive (Bosniak III
and IV) versus negative (Bosniak I, II and IIF) diagnostic test
results. The reference standard for malignant and benign di-
agnoses was defined as the final diagnosis confirmed by his-
topathology and/or follow-up. For calculation of sensitivity
and specificity, a diagnostic random-effects model, using the
method of DerSimonian and Laird, was used. For calculation
purposes, a correction factor of 0.5 was added to zero findings.
A summary receiver operating characteristic (ROC) curve was
constructed by using a bivariate (maximum likelihood) model.
Again, data heterogeneity was assessed by I2-statistics.
Meta-regression was applied to investigate the possible in-
fluence of variables (sample size of the respective study, ref-
erence standard – histopathology only or histopathology and/
or follow-up, study published before or after the introduction
of the Bosniak IIF category, benign lesions only, including
Bosniak IIF or also Bosniak I and/or II) and technical factors
including slice thickness (grouped as ≤5, ≤10 or not given),
detector rows (grouped as: up to 4, 16, 64 or higher and not
given) or whether there was any technical information given
or not on sensitivity and specificity. P-values of <0.05 were
interpreted as indicating a significant result.
Finally, publication bias was assessed by construction of
funnel plots and Deek’s test for funnel plot asymmetry.
Results
Study characteristics, bias
Overall, 35 eligible studies were selected (Fig. 1, Tables 2
and 3). In our meta-analysis, a total of 2,557 patients with
2,578 lesions (862 malignant lesions, 33.4 %) were includ-
ed. QUADAS 2 assessment (Fig. 2) revealed a mixed risk
of bias assessment regarding patient selection: A number
of studies used only histopathology as the only reference
standard, patient recruitment was non-consecutive or insuf-
ficient details regarding patient recruitment were given. In
addition, benign lesions regularly contained only Bosniak
IIF or Bosniak II and IIF cysts but no Bosniak I lesions
[7–32]. No further risk of bias concerns was raised and all
included studies were deemed applicable to answer the
research question (Fig. 2). The study designs were
Fig. 1 Flowchart showing the study selection process
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described as prospective in one study [19] and retrospec-
tive in 33 studies [7–17, 20–41]. In one study [18], the
retrospective or prospective character of the study could
not be determined. Patient recruitment was consecutive in
seven studies [13, 18, 19, 34, 39, 41]. Seven reports de-
scribed non-consecutive [7, 8, 14, 24, 26, 36, 40] case-
control patient recruitment. In another 21 studies, the con-
secutive or non-consecutive nature of patient recruitment
was not clearly stated [9, 10, 12, 15–17, 20, 21, 23, 25,
27–33, 35–38]. Histopathology as a reference standard was
used in 13 studies [7, 12, 15–17, 22, 28, 29, 31, 32, 35, 37,
41], follow-up and histopathology in another 21 studies
[8–11, 13, 14, 18–21, 23–27, 30, 33, 34, 36, 38, 39], and,
in one study only, follow-up was used as the reference
standard [40]. Twenty-five of 35 (71.4 %) eligible studies
provided technical information on computed tomography
[7, 9–11, 13, 14, 16–19, 21, 23–27, 29, 31–33, 35, 36, 38,
39, 41] (Table 1). However, this information was incom-
plete in the majority of the investigated studies and almost
all studies investigated their patients on several devices
with varying protocols (Table 2). The number of observers
reading CT images (range 1–3 readers) was provided in 21













Aronson [29] 1991 16 n.a GE 1 n.a n.a
Cloix [35] 1996 30 6–86 n.a n.a 10 n.a
Wilson [38] 1996 20 n.a GE n.a 5–10 n.a
Siegel [34] 1997 46 n.a n.a n.a n.a n.a.
Bielsa [12] 1999 19 n.a n.a n.a n.a n.a
Curry [33] 2000 109 3–120 n.a n.a 3–10 n.a.
Koga [37] 2000 35 n.a n.a n.a n.a n.a
Limb [28] 2002 57 6–70 n.a n.a n.a n.a
Lang [31] 2002 22 67.2 GE/Philips/Siemens n.a. n.a n.a
Israel, Bosniak [21] 2003 41 2–18 n.a n.a 3–10 n.a.
Israel [11] 2003 81 13–209 n.a n.a 3–10 n.a
Harisinghani [27] 2003 28 12–24 GE Medical Systems n.a 5 ‘Specialty-trained’
Israel [36] 2004 59 48 GE/Siemens 2.5–5 n.a
Spaliviero [41] 2005 50 14 Siemens 4; 16 ≤5 n.a
Loock [20] 2006 37 n.a n.a n.a n.a n.a
Ascenti [19] 2007 40 12–24 Siemens 1; 16 3–5 15, 25, 10
Quaia [13] 2008 40 n.a Philips/Toshiba 1, n.a. 3–5 2–8
Clevert [18] 2008 32 3–24 Siemens 64 ≤3 n.a
Song [7] 2009 104 n.a GE/Siemens 4; 16 2,5 n.a.
O’Malley [8] 2009 112 15 n.a n.a. n.a. ‘faculty’
Grotemeyer [40] 2009 25 n.a n.a n.a n.a n.a
Peng [39] 2010 22 n.a GE 64 5 n.a.
Weibl [9] 2011 104 60 n.a 5 4–30
Pinheiro [15] 2011 36 n.a n.a n.a n.a n.a
You [16] 2011 53 n.a GE, Siemens 4; 16 2.5 n.a
Smith [10] 2012 193 45,6 (IIF) 52,8(III) Siemens 4–64 3–5 ‘Fellowship-trained’
Han [17] 2012 97 n.a GE 64 n.a. 10
Hwang [26] 2012 201 20 GE, Siemens 4; 16 2,5–5 n.a
Graumann [14] 2013 32 24–60 Siemens 4 2,5 5–20
Reese [22] 2014 133 n.a n.a n.a n.a n.a
Hindman [23] 2014 144 6–157 GE, Siemens 1; 4; 16; 64 3–8 7, 11, 52
Kim [25] 2014 164 24 GE, Siemens 16, 64 2.5–5 2–12
El-Mokadem [30] 2014 124 24 n.a n.a n.a n.a.
Bata [32] 2014 19 n.a. Philips 16 2 6
Weibl [24] 2015 85 43 n.a n.a. 2.5–5 n.a.
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studies [7–11, 13–15, 17, 19, 22–25, 27, 30, 32, 34,
36–38]. Observer experience (range 2–52 years’ experi-
ence) in CT was given in ten studies only [9, 10, 13, 14,
17, 19, 22, 23, 25, 32] (Table 1). Inter-observer variability
based on kappa analysis (kappa range 0.571–1) was pro-
vided in five studies [13, 19, 23, 30, 34]. Eight studies
were carried out before the introduction of the Bosniak
IIF category [12, 28, 29, 33–35, 37, 38] and the remaining
27 studies after the introduction of Bosniak IIF [7–11,
13–20, 22–27, 30–32, 36, 39–41].
Rate of malignancy in Bosniak categories
The rate of malignancy increased from Bosniak I to IV
(Fig. 3 and Supplemental Material Fig. A1–A3). Pooled
estimates were 3.2 % (95 % CI 0–6.8) in 89 Bosniak I,
6 % (95 % CI 2.7–9.3) in 261 Bosniak II, 6.7 % (95 % CI
5–8.4) in 818 Bosniak IIF, 55.1 % (95 % CI 45.7–64.5) in
887 Bosniak III and 91 % (95 % CI 87.7–94.2) in 449
Bosniak IV lesions. Malignancy rates did not differ be-
tween Bosniak I, II and IIF (P-values I vs. II: 0.309, II vs.
Table 3 Reference standard and key diagnostic parameters extracted from the investigated studies
Author Year SOR Diagnostic study:
0 = no, 1 = yes, 2 = yes,
restricted to IIF benign
Lesions TP FN FP TN Prevalence 95 % CI
Aronson [29] 1991 Histology 1 20 12 0 4 4 60.0 36.1–80.9
Cloix [35] 1996 Histology 1 32 11 2 12 7 43.3 23.7–59.4
Wilson [38] 1996 Histology/FU 1 22 10 4 0 8 93.3 40.7–82.8
Siegel [34] 1997 Histology/FU 1 70 31 1 9 29 66.7 33.8–58.1
Bielsa [12] 1999 Histology 1 20 10 1 2 7 55.0 31.5–76.9
Curry [33] 2000 Histology/FU 1 82 47 0 20 15 60.3 45.9–68.2
Koga [37] 2000 Histology 1 35 22 1 0 12 95.8 47.8–80.9
Limb [28] 2002 Histology 1 57 8 3 21 25 19.3 10.1–31.9
Lang [31] 2002 Histology 2 152 17 5 101 29 14.5 9.3–21.1
Israel and Bosniak [21] 2003 Histology/FU 0 42 0 2 0 40 4.8 0.6–16.2
Israel [11] 2003 Histology/FU 1 81 25 0 16 40 30.9 21.7–42.1
Harisinghani [27] 2003 Histology/FU 0 28 17 0 11 0 60.7 40.6–78.5
Israel [36] 2004 Histology/FU 1 69 20 0 8 41 37.0 18.7–41.2
Spaliviero [41] 2005 Histology 1 47 25 4 8 10 63.0 46.4–75.5
Loock [20] 2006 Histology/FU 1 37 10 2 11 14 32.4 18.0–49.8
Ascenti [19] 2007 Histology/FU 1 44 5 0 5 34 11.4 3.8–24.6
Quaia [13] 2008 Histology/FU 1 40 23 0 8 9 57.5 40.9–73.0
Clevert [18] 2008 Histology/FU 1 37 10 0 5 22 27.0 13.8–44.1
Song [7] 2009 Histology 1 104 53 3 22 26 53.8 43.8–63.7
O’Malley [8] 2009 Histology/FU 2 107 27 5 6 69 29.9 21.4–39.5
Grotemeyer [40] 2009 FU 0 25 0 0 0 25 0.0 0.0–13.7
Peng [39] 2010 Histology/FU 1 24 17 0 2 5 77.3 48.9–87.4
Weibl [9] 2011 Histology/FU 1 113 45 2 27 39 41.6 32.4–51.2
Pinheiro [15] 2011 Histology 0 37 24 0 13 0 64.9 47.5–79.8
You [16] 2011 Histology 0 75 53 0 22 0 70.7 59.0–80.6
Smith [10] 2012 Histology/FU 2 213 58 4 86 65 29.1 23.1–35.7
Han [17] 2012 Histology 1 97 50 3 21 23 54.6 44.2–64.8
Hwang [26] 2012 Histology/FU 0 201 0 10 0 191 5.0 2.4–9.0
Graumann [14] 2013 Histology/FU 0 32 0 2 0 30 6.3 0.8–20.8
Reese [22] 2014 Histology 1 113 71 4 20 18 66.4 56.9–75.0
Hindman [23] 2014 Histology/FU 0 80 0 7 0 73 8.8 3.6–17.2
Kim [25] 2014 Histology/FU 1 164 52 6 16 90 35.4 28.1–43.2
El-Mokadem [30] 2014 Histology/FU 2 100 22 7 8 63 29.0 20.4–38.9
Bata [32] 2014 Histology 0 19 16 0 3 0 84.2 67.8–100
Weibl [24] 2015 Histology/FU 2 85 37 8 21 19 52.9 41.8–63.9
SOR standards of reference, FU follow-up
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IIF: 0.690, I vs. IIF: 0.199) and were higher in Bosniak III
(P-values vs. IIF <0.0001) but lower than in Bosniak IV
(P < 0.0001).
Two Bosniak I cysts were malignant: one an RCC upgraded
by ultrasound [35] and one an incidental focal area (0.6 cm) of
papillary RCC within a larger cyst [41]. Six studies provided
details on benign Bosniak IV lesions: these were either smaller
than 2 cm [17], haemorrhagic cysts [20, 35], cystic nephroma
[15, 34, 39] or oncocytoma [15, 35], or simple cysts [35].
Meta-regression identified a higher rate of malignancy
in Bosniak IIF lesions in studies that used histopathology
as the only reference standard (16.6 %, 95 % CI 7.7–
25.4), compared to studies that also accepted follow-up
examinations as a reference standard (6.3 %, 95 % CI
4.6–8.0). Year of publication was associated with a trend
towards higher malignancy rates (P = 0.05). No further
influencing factors on the rate of malignancy were identi-
fied in any Bosniak category (P > 0.05, respectively).
Between-studies heterogeneity was low in Bosniak I
(I2 = 5 %) and IIF (I2 = 0 %), medium in Bosniak II
(I2 = 32 %) and Bosniak IV (I2 = 36 %), and high in
Bosniak III (I2 = 89 %) cysts.
Diagnostic performance of the Bosniak classification
Twenty-six studies provided information about the diagnostic
performance of the Bosniak classification by including benign
and malignant lesions classified as benign (Bosniak < III) or
malignant (Bosniak ≥ III) by imaging [7–13, 17–20, 22, 24,
25, 28–31, 33–39, 41].
The area under the summary ROC (sROC) curve (bivariate
model) was calculated as 92 % (95 % CI 89–94; Fig. 4).
Overall pooled sensitivity and specificity were 93 % (95 %
CI 89–95) and 67 % (95 % CI 59–76). Between-study hetero-
geneity was high (I2 for sensitivity: 68.5 %, I2 for specificity:
90.9 %).
A subgroup analysis in diagnostic studies that included
histopathology only as the standard of reference, and non-
selected Bosniak categories [7, 12, 17, 22, 28, 29, 35, 37,
41], revealed a lower sROC AUC of 0.86 (95 % CI 0.83–
0.89). A higher AUC of 0.94 (95 % CI 0.91–0.96) was found
in 12 diagnostic studies that included histopathology and
follow-up as the standards of reference [9, 11, 13, 18–20,
25, 33, 34, 36, 38, 39]. This group reflects the clinical setting
most accurately, and a pooled (bivariate model) sensitivity of
97 % (95 % CI 86–99, I2 = 70.7 %) and a specificity of 74 %
(95 % CI 64–82, I2 = 77.2 %) were calculated.
Fig. 2 QUADAS 2 assessment results
Fig. 3 Forest plot of pooled malignancy rates (random effects model) in
Bosniak categories
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Meta-regression (random effects model) identified a lower
sensitivity in studies that included only Bosniak IIF lesions as
benign (meta-regression coefficient -0.76, 95 % CI -1.39 to -
0.13, P = 0.018). Further, meta-regression demonstrated a sig-
nificantly higher specificity in studies that used histopatholo-
gy and follow-up as the reference standard as compared to
studies with histopathology as reference standard only (me-
ta-regression coefficient 0.92, 95 % CI 0.24–1.59, P = 0.008).
Technical factors including slice thickness, detector rows or
whether there was any technical information given at all did
not show a significant influence on either sensitivity or spec-
ificity (P > 0.05, respectively). In addition, year of publication
was not associated with these diagnostic performance indices
(P > 0.05, respectively). No evidence of publication bias was
found (Deek’s test P = 0.61; Supplemental Material Fig. B).
Discussion
Our results demonstrate an increasing malignancy rate from
Bosniak I to IV categories. Between-study heterogeneity
ranged from low to high, with the highest value observed in
Bosniak III lesions. Bosniak III cysts are defined as complex
cysts and must be differentiated from minimally complex
cysts (IIF) that can be managed with only follow-up. We did
not identify any explanatory variable for the observed hetero-
geneity in Bosniak III lesions. However, two factors very like-
ly contributing to this heterogeneity, namely, reader experi-
ence and spatial resolution, were insufficiently reported in
the majority of included studies. Bosniak IIF cysts were more
likely to be malignant if the study considered only histopa-
thology as the standard of reference. As the rate of true-
negative findings, and, subsequently, the malignancy rate, de-
pends on whether clinically benign findings that are not
subject to histopathological sampling are considered, a study
design-related selection bias did appear to be present. The low
to medium heterogeneity in Bosniak I, II and IV categories
that was accompanied by a low (Bosniak I, II) or high
(Bosniak IV) malignancy rate strongly suggests that the lim-
itations of the Bosniak classification lie in a less-than-optimal
grading of lesion complexity using the Bosniak IIF and III
categories. This is underlined by the fact that the introduction
of the Bosniak IIF category did not significantly affect the
overall diagnostic performance of the Bosniak classification.
In addition, the low but not very low malignancy rates of
Bosniak II and IIF categories did not differ. These findings
seem to suggest that Bosniak II lesions should be followed up
in a similar way to IIF lesions. Again, selection bias might
lead to an overestimation of malignancy rates in these lesions.
Overall, the Bosniak classification showed a sensitivity of
89.6 % and a specificity of 65.1 %. Meta-regression identified
a lower sensitivity in studies that included only Bosniak IIF
lesions as benign. This finding was attributed to the fact that
there was a higher prevalence of malignancy in Bosniak IIF
compared to the Bosniak II and I categories. Consequently,
the rate of false-negative findings was higher per study design
than in the case of a non-selected inclusion of all non-surgical
Bosniak categories (I, II and IIF). In addition, study design-
related specificity was lower in studies that used surgical ver-
ification only as the standard of reference. A higher rate of
true-negative findings is to be expected when follow-up was
used as the reference standard, as true-negative findings with-
out subsequent surgery are not considered in a study consid-
ering histopathologically verified lesions only. In the latter
case, specificity is expected to be lower. Consequently, we
identified the best diagnostic performance for the Bosniak
classification system in those studies most representative of
the clinical setting: non-selected lesion inclusion and
Fig. 4 Summary receiver operating characteristic (ROC) curves based on
bivariate (maximum likelihood) models for 26 diagnostic studies (left), a
subgroup of 12 diagnostic studies with both histopathology and follow-
up (FU) as standards of reference (SOR) (middle), and nine diagnostic
studies using only histopathology as the SOR (right). Note a significantly
(P < 0.001) higher area under the ROC curve (AUC) based on a higher
(P < 0.001) specificity in studies with both histopathology and FU as the
SOR, compared to histopathology only. The summary statistics in the
middle most accurately reflect the clinical application of the Bosniak
classification
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considering follow-up examination results in addition to his-
topathological work-up. Here, sensitivity was very high; con-
versely, the negative likelihood ratio was very low. This leads
us to conclude that a negative Bosniak finding (Bosniak cat-
egory < III) will sufficiently exclude malignancy. However,
pooled specificity and positive likelihood ratios were rather
mediocre. As false-positive findings regularly result in unnec-
essary treatment, or at least invasive diagnostic procedures,
further research is needed to improve risk stratification and
evidence-based clinical practice guidelines, especially for the
management of Bosniak IIF and III findings. Accurate risk
stratification would be a prerequisite for the adequate use of
active surveillance strategies. However, our systematic review
did not provide the data to resolve this issue.
The diagnosis of indeterminate cystic renal lesions may be
improved by using additional imaging methods, such as
contrast-enhanced ultrasound and magnetic resonance imaging
(MRI). Contrast-enhanced ultrasound (CEUS) improves diagno-
sis by detecting fine enhancing septa and tumour vascularity in
complex cysts [13, 42–44]. Similar diagnostic improvements
can be obtained with MRI, which provides high soft-tissue con-
trast for the evaluation of septa and solid contrast-enhancing
lesion parts. Israel et al. found a similar malignancy rate when
comparing CTandMRI in 69 renal lesions.MRI had a tendency
to upgrade the lesions: in 18 of 20 malignant lesions, CT and
MRI agreed completely with regard to the Bosniak categoriza-
tion, while MRI upgraded two CT Bosniak III lesions to
Bosniak IV [36]. Chen et al. also compared CEUS and MRI
of complex cystic renal masses and found a higher sensitivity
and accuracy of CEUS (97.2 % and 84.5 %, respectively), but a
lower specificity (71.4 %) versus 80.6 %, 78.9 %, and 77.1 %,
respectively, for MRI [45]. These additional diagnostic tools
have shown promising results with regard to lesion characteri-
zation. While CEUS is a relatively simple examination, MRI is
considered rather time-consuming and expensive. In addition,
minimally invasive percutaneous biopsies have a potential role
in the management of renal cysts by separating surgical from
non-surgical lesions and the value of this technique is currently
under investigation. A detailed discussion on this topic is beyond
the scope of this study, but there is a recent and comprehensive
systematic review of new modalities for the diagnosis of com-
plex renal cysts published by Ellimootill and co-workers [46].
Some limitations of our systematic review and meta-
analysis warrant discussion. Amajority of the studies included
in our work provided insufficient data about technical and
reading conditions. As most studies recruited their cases over
a longer period of time, scanners and protocols were not kept
constant. Extractable technical parameters and year of publi-
cation (assuming that year of publication and equipment are
associated) did not show a significant influence on the diag-
nostic performance of the Bosniak classification according to
our additional meta-regression analysis. Therefore, our analy-
sis did not show a diagnostic impact of improved CT
technology using the Bosniak classification for diagnosis of
cystic renal lesions. However, as demonstrated in the results,
technical influences on reader performance remain a research
gap in this field. Further, observer experience and inter-
observer variation were largely unexplored. As a conse-
quence, there is an additional research gap regarding the rate
of lesions with inconclusive or equivocal findings and the
subsequent inability to determine a definitive Bosniak classi-
fication. In addition, the majority of studies were retrospec-
tive. Although we were able to identify several study design-
related influences on malignancy rates and diagnostic param-
eters, a large amount of between-study heterogeneity remains
unexplained. Again, these limitations should be seen as re-
search gaps, highlighting where further research is necessary.
In conclusion, our meta-analysis provides quantitative
summaries of malignancy rates in Bosniak categories.
Strong heterogeneity in Bosniak IIF and III subgroups indi-
cates the need for further research for improved clinical man-
agement of complex renal cysts. Considering studies most
appropriately reflecting clinical practice, the Bosniak classifi-
cation can accurately rule out malignancy, but its specificity
remains moderate. The Bosniak classification is an accurate
tool with which to stratify the risk of malignancy in renal
cystic lesions and is seemingly robust along various protocols
and CT scanner generations. Research gaps with regard to the
clinical application of the Bosniak classification include a lack
of data about reader experience and inter-reader variability,
and the diagnostic influence of technical CT parameters.
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